Literature DB >> 7943121

Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.

A P Adamis1, J W Miller, M T Bernal, D J D'Amico, J Folkman, T K Yeo, K T Yeo.   

Abstract

The vitreous levels of the angiogenic polypeptide vascular endothelial growth factor (also known as vascular permeability factor) were measured and compared in eyes with and without proliferative diabetic retinopathy. Undiluted vitreous samples from 20 eyes were collected at the time of vitrectomy, and vascular endothelial growth factor levels were determined by using a time-resolved immunofluorometric assay. Vitreous vascular endothelial growth factor levels were significantly higher in eyes with proliferative diabetic retinopathy than in eyes without proliferative diabetic retinopathy (P = .006; Wilcoxon Rank Sum Test). The median vitreous concentration in the eyes with proliferative diabetic retinopathy was 29.1 pM and exceeded the known concentration required for the maximal proliferation of vascular endothelial cells in vitro. These data are consistent with vascular endothelial growth factor serving as a physiologically relevant angiogenic factor in proliferative diabetic retinopathy.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7943121     DOI: 10.1016/s0002-9394(14)75794-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  318 in total

Review 1.  Glucose, VEGF-A, and diabetic complications.

Authors:  L E Benjamin
Journal:  Am J Pathol       Date:  2001-04       Impact factor: 4.307

2.  Is diabetic retinopathy an inflammatory disease?

Authors:  A P Adamis
Journal:  Br J Ophthalmol       Date:  2002-04       Impact factor: 4.638

3.  Reversal of experimental diabetic neuropathy by VEGF gene transfer.

Authors:  P Schratzberger; D H Walter; K Rittig; F H Bahlmann; R Pola; C Curry; M Silver; J G Krainin; D H Weinberg; A H Ropper; J M Isner
Journal:  J Clin Invest       Date:  2001-05       Impact factor: 14.808

Review 4.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

Review 5.  Vitreous proteomics and diabetic retinopathy.

Authors:  Saloni Walia; Allen C Clermont; Ben-Bo Gao; Lloyd Paul Aiello; Edward P Feener
Journal:  Semin Ophthalmol       Date:  2010 Sep-Nov       Impact factor: 1.975

6.  Intravitreal growth factors in proliferative diabetic retinopathy: correlation with neovascular activity and glycaemic management.

Authors:  M Boulton; Z Gregor; D McLeod; D Charteris; J Jarvis-Evans; P Moriarty; A Khaliq; D Foreman; D Allamby; B Bardsley
Journal:  Br J Ophthalmol       Date:  1997-03       Impact factor: 4.638

Review 7.  Anti-vascular endothelial growth factor therapy for diabetic macular edema.

Authors:  David S Boyer; J Jill Hopkins; Jonathan Sorof; Jason S Ehrlich
Journal:  Ther Adv Endocrinol Metab       Date:  2013-12       Impact factor: 3.565

8.  Recognizing intraventricular silicone.

Authors:  Jonathan J Mayl; Miguel A Flores; John W Stelzer; Bo Liu; Steven A Messina; John V Murray
Journal:  Emerg Radiol       Date:  2018-02-03

9.  Proteolytic cleavage of vascular adhesion protein-1 induced by vascular endothelial growth factor in retinal capillary endothelial cells.

Authors:  Shiho Yoshida; Miyuki Murata; Kousuke Noda; Takashi Matsuda; Michiyuki Saito; Wataru Saito; Atsuhiro Kanda; Susumu Ishida
Journal:  Jpn J Ophthalmol       Date:  2018-02-01       Impact factor: 2.447

10.  VEGF localisation in diabetic retinopathy.

Authors:  M Boulton; D Foreman; G Williams; D McLeod
Journal:  Br J Ophthalmol       Date:  1998-05       Impact factor: 4.638

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.